Financials
Income statement
Fiscal date | 2025 | 2024 | 2023 | 2022 |
---|---|---|---|---|
Total reported revenue | 1.7T | 1.5T | 1.4T | 1.2T |
Cost of revenue | 545.0B | 535.5B | 512.7B | 454.0B |
Gross profit | 1.2T | 964.3B | 878.7B | 711.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 114.6B | 85.7B | 76.7B | 57.1B |
Other operating expenses | 75.5B | 33.7B | 39.6B | 33.5B |
Operating income | 475.9B | 398.9B | 352.0B | 247.6B |
Non operating interest income | ||||
Income | — | 6.5B | 3.1B | 2.2B |
Expense | 217.5B | 159.6B | 143.0B | 132.5B |
Other income expense | — | — | — | — |
Pretax income | 384.0B | 126.8B | 165.6B | 124.8B |
Tax provision | 9.2B | 41.2B | 42.7B | 41.8B |
Net income | 374.8B | 85.6B | 122.9B | 83.1B |
Basic EPS | — | 13.1 | 14.8 | 7.7 |
Diluted EPS | — | 12.8 | 14.6 | 7.6 |
Basic average shares | — | 5.7M | 5.6M | 5.5B |
Diluted average shares | — | 5.7M | 5.6M | 5.5B |
EBITDA | 984.4B | 769.9B | 681.5B | 572.3B |
Net income from continuing op. | 384.0B | 126.8B | 165.6B | 124.8B |
Minority interests | -39.3B | -10.9B | -39.4B | -40.5B |
Preferred stock dividends | 0 | 0 | 0 | 0 |